CA116-003
Application for participants in Bristol Myers Squibb CA116-003 study.
Developer: Medable Inc.
App Size: Varies With Device
Release Date: Oct 18, 2022
Price: Free
Medical
CA116-003
Screenshots for App
Mobile
You are invited to participate in the Bristol Myers Squibb CA116-003 study. This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms.
More Information about: CA116-003
Price:
Free
Version:
v1.0.0
Downloads:
8
Compatibility:
Android 6.0
Bundle Id:
com.medable.bms.ca116003
Size:
Varies With Device
Last Update:
2022-10-19
Content Rating:
Everyone
Release Date:
Oct 18, 2022
Content Rating:
Everyone
Developer:
Medable Inc.
Developer Apps
Related Apps
ELEMENT-MDS Participant App
